TBPL1
gene geneOn this page
Also known as TLPSTUDTRF2TLF
Summary
TBPL1 (TATA-box binding protein like 1, HGNC:11589) is a protein-coding gene on chromosome 6q23.2, encoding TATA box-binding protein-like 1 (P62380). Part of a specialized transcription system that mediates the transcription of most ribosomal proteins through the 5’-TCT-3’ motif which is a core promoter element at these genes.
This gene encodes a member of the TATA box-binding protein family. TATA box-binding proteins play a critical role in transcription by RNA polymerase II as components of the transcription factor IID (TFIID) complex. The encoded protein does not bind to the TATA box and initiates transcription from TATA-less promoters. This gene plays a critical role in spermatogenesis, and single nucleotide polymorphisms in this gene may be associated with male infertility. Alternatively spliced transcript variants have been observed for this gene, and a pseudogene of this gene is located on the long arm of chromosome 3.
Source: NCBI Gene 9519 — RefSeq curated summary.
At a glance
- GWAS associations: 3
- Clinical variants (ClinVar): 13 total
- Transcription factor: yes — 43 downstream targets (CollecTRI)
- MANE Select transcript:
NM_004865
Identifiers
Gene identifiers
| Field | Value |
|---|---|
| HGNC ID | HGNC:11589 |
| Approved symbol | TBPL1 |
| Name | TATA-box binding protein like 1 |
| Location | 6q23.2 |
| Locus type | gene with protein product |
| Status | Approved |
| Aliases | TLP, STUD, TRF2, TLF |
| Ensembl gene | ENSG00000028839 |
| Ensembl biotype | protein_coding |
| OMIM | 605521 |
| Entrez | 9519 |
Gene structure
Transcript identifiers
Ensembl transcripts: 8 — 6 protein_coding, 2 protein_coding_CDS_not_defined
ENST00000237264, ENST00000367869, ENST00000367871, ENST00000416965, ENST00000457715, ENST00000477527, ENST00000481694, ENST00000613034
RefSeq mRNA: 2 — MANE Select: NM_004865
NM_001253676, NM_004865
CCDS: CCDS5168
Canonical transcript exons
ENST00000237264 — 7 exons
| Exon | Start | End |
|---|---|---|
| ENSE00000798782 | 133982568 | 133982650 |
| ENSE00001445816 | 133953224 | 133953425 |
| ENSE00003515009 | 133982817 | 133982880 |
| ENSE00003539569 | 133984577 | 133984671 |
| ENSE00003651011 | 133986961 | 133990432 |
| ENSE00003791632 | 133984376 | 133984479 |
| ENSE00003799061 | 133980082 | 133980260 |
Expression profiles
Bgee: expression breadth ubiquitous, 288 present calls, max score 99.25.
FANTOM5 (CAGE): breadth ubiquitous, TPM avg 37.6284 / max 410.9384, expressed in 1820 samples.
FANTOM5 promoters (7 alternative TSS)
| Promoter ID | TPM avg | Samples expressed |
|---|---|---|
| 69865 | 33.9738 | 1819 |
| 69864 | 2.7411 | 1419 |
| 69860 | 0.4041 | 54 |
| 69862 | 0.3043 | 137 |
| 69859 | 0.1560 | 46 |
| 69858 | 0.0468 | 9 |
| 69861 | 0.0023 | 1 |
Top tissues by expression
296 total, by Bgee expression score (0-100, higher = more expressed):
| Tissue | Anatomy ID | Expression score | Quality |
|---|---|---|---|
| oocyte | CL:0000023 | 99.25 | gold quality |
| secondary oocyte | CL:0000655 | 98.81 | gold quality |
| left testis | UBERON:0004533 | 98.39 | gold quality |
| right testis | UBERON:0004534 | 98.19 | gold quality |
| adult organism | UBERON:0007023 | 97.36 | gold quality |
| testis | UBERON:0000473 | 97.19 | gold quality |
| sperm | CL:0000019 | 97.17 | gold quality |
| cortical plate | UBERON:0005343 | 96.69 | gold quality |
| male germ cell | CL:0000015 | 96.65 | gold quality |
| ganglionic eminence | UBERON:0004023 | 96.52 | gold quality |
| primordial germ cell in gonad | CL:0000670 ∩ UBERON:0000991 | 95.21 | gold quality |
| prefrontal cortex | UBERON:0000451 | 94.65 | gold quality |
| Brodmann (1909) area 9 | UBERON:0013540 | 94.47 | gold quality |
| middle temporal gyrus | UBERON:0002771 | 94.22 | gold quality |
| cerebellar hemisphere | UBERON:0002245 | 94.21 | gold quality |
| cerebellar cortex | UBERON:0002129 | 94.19 | gold quality |
| right frontal lobe | UBERON:0002810 | 94.02 | gold quality |
| right hemisphere of cerebellum | UBERON:0014890 | 93.89 | gold quality |
| dorsolateral prefrontal cortex | UBERON:0009834 | 93.67 | gold quality |
| monocyte | CL:0000576 | 93.42 | gold quality |
| granulocyte | CL:0000094 | 93.40 | gold quality |
| leukocyte | CL:0000738 | 93.27 | gold quality |
| mononuclear cell | CL:0000842 | 93.20 | gold quality |
| adenohypophysis | UBERON:0002196 | 93.19 | gold quality |
| cingulate cortex | UBERON:0003027 | 93.05 | gold quality |
| male germ line stem cell (sensu Vertebrata) in testis | CL:0000089 ∩ UBERON:0000473 | 92.97 | gold quality |
| endothelial cell | CL:0000115 | 92.96 | gold quality |
| embryo | UBERON:0000922 | 92.94 | gold quality |
| cerebellum | UBERON:0002037 | 92.93 | gold quality |
| anterior cingulate cortex | UBERON:0009835 | 92.91 | gold quality |
Single-cell (SCXA)
Detected in 1 experiment(s), a significant marker in 1.
| Experiment | Marker? | Max mean expression |
|---|---|---|
| E-ANND-3 | yes | 4.41 |
Regulation
Is transcription factor: yes
Downstream targets (CollecTRI)
43 targets.
| Target | Regulation |
|---|---|
| ACHE | |
| C6 | |
| CD44 | |
| CD74 | |
| CDKN1A | |
| CXCL11 | |
| DNTT | |
| EDN1 | |
| FOS | Repression |
| GSTP1 | |
| GTF2A1 | |
| GTF2B | |
| H1-2 | |
| LCT | |
| MC1R | |
| MT-ATP6 | |
| NF1 | Activation |
| OXTR | |
| PAM | |
| PCNA | |
| PDP1 | |
| PMEL | |
| POLI | |
| POT1 | |
| SLC3A1 | |
| SLU7 | |
| SPI1 | |
| SPINT2 | |
| SULT2A1 | |
| TAF7 |
Upstream regulators (CollecTRI, top): NKX3-1, TBPL1, TP53
miRNA regulators (miRDB)
90 targeting TBPL1, top 30 by miRDB confidence (max_score; target_count = how many genes the miRNA targets in total — lower means more specific):
| miRNA | Max score | Avg score | miRNA target_count |
|---|---|---|---|
| HSA-MIR-4668-3P | 100.00 | 68.74 | 2635 |
| HSA-MIR-9-5P | 100.00 | 72.28 | 2361 |
| HSA-MIR-4262 | 100.00 | 73.26 | 3931 |
| HSA-MIR-30A-5P | 100.00 | 76.31 | 3233 |
| HSA-MIR-30B-5P | 100.00 | 76.29 | 3248 |
| HSA-MIR-30C-5P | 100.00 | 76.29 | 3248 |
| HSA-MIR-30D-5P | 100.00 | 76.32 | 3233 |
| HSA-MIR-30E-5P | 100.00 | 76.32 | 3242 |
| HSA-MIR-196A-5P | 100.00 | 68.16 | 684 |
| HSA-MIR-196B-5P | 100.00 | 68.16 | 681 |
| HSA-MIR-181A-5P | 99.99 | 72.96 | 2995 |
| HSA-MIR-181B-5P | 99.99 | 72.97 | 2996 |
| HSA-MIR-181C-5P | 99.99 | 72.95 | 2996 |
| HSA-MIR-181D-5P | 99.99 | 73.04 | 2997 |
| HSA-MIR-513B-5P | 99.99 | 69.96 | 2150 |
| HSA-MIR-371B-5P | 99.99 | 75.34 | 4759 |
| HSA-MIR-373-5P | 99.98 | 75.36 | 4753 |
| HSA-MIR-616-5P | 99.98 | 75.58 | 4775 |
| HSA-MIR-103A-3P | 99.98 | 69.14 | 1595 |
| HSA-MIR-107 | 99.98 | 69.14 | 1595 |
| HSA-MIR-3148 | 99.97 | 75.06 | 6478 |
| HSA-MIR-3688-3P | 99.97 | 72.02 | 2834 |
| HSA-MIR-497-5P | 99.92 | 71.83 | 2674 |
| HSA-MIR-5195-3P | 99.92 | 70.92 | 1877 |
| HSA-MIR-145-5P | 99.92 | 71.13 | 1836 |
| HSA-MIR-454-3P | 99.91 | 74.01 | 1925 |
| HSA-MIR-15A-5P | 99.90 | 72.80 | 2787 |
| HSA-MIR-15B-5P | 99.90 | 72.78 | 2798 |
| HSA-MIR-16-5P | 99.90 | 72.80 | 2780 |
| HSA-MIR-195-5P | 99.90 | 72.81 | 2805 |
Literature-anchored findings (GeneRIF, showing 9)
- Data show that during interphase, endogenous or exogenously expressed TRF2 is located almost exclusively in the nucleolus (PMID:15269281)
- TLF is a functional regulator of transcription with targets distinct from those of TBP. (PMID:15767669)
- the knockdown of the endogenous TLP reduced etoposide-induced apoptosis through repression of TAp63 expression. Taken together, our present study identifies a TLP-TAp63 pathway that is further implicated in stress-induced apoptosis. (PMID:19858204)
- TLP mediates p53-governed transcriptional activation of the p21 upstream promoter. (PMID:22511763)
- results suggest that activation of the p21 upstream promoter is mediated by interaction between specific regions of TLP and p53 (PMID:24594805)
- Western blotting and immunohistochemistry both indicated a higher TBPL1 protein expression level in colorectal cancer tissue. siRNA for TBPL1 transfection obviously slowed down the cell proliferation in both SW-620 and HT-29 cells. (PMID:24870791)
- miR18a exhibits a protective role in colorectal cancer (CRC) via inhibiting proliferation, invasion and migration of CRC cells by directly targeting the TBPL1 gene. (PMID:26398009)
- The interaction of TBP-like protein with TFIIA is essential to suppress proteasome-dependent turnover of TBP-like protein (PMID:27696626)
- TLP Prevents p53 Degradation through Disrupting the p53-MDM2 Interaction. (PMID:28082682)
Cross-species orthologs
5 orthologs
| Organism | Symbol | Gene ID |
|---|---|---|
| danio_rerio | tbpl1 | ENSDARG00000036868 |
| mus_musculus | Tbpl1 | ENSMUSG00000071359 |
| rattus_norvegicus | Tbpl1 | ENSRNOG00000066988 |
| drosophila_melanogaster | Trf2 | FBGN0261793 |
| caenorhabditis_elegans | tlf-1 | WBGENE00006577 |
Paralogs (2): TBP (ENSG00000112592), TBPL2 (ENSG00000182521)
Protein
Protein identifiers
TATA box-binding protein-like 1 — P62380 (reviewed: P62380)
Alternative names: 21 kDa TBP-like protein, Second TBP of unique DNA protein, TATA box-binding protein-related factor 2, TBP-like factor, TBP-related protein
All UniProt accessions (5): P62380, Q7Z6T9, Q7Z6U0, Q7Z6U1, Q7Z6U2
UniProt curated annotations — full annotation on UniProt →
Function. Part of a specialized transcription system that mediates the transcription of most ribosomal proteins through the 5’-TCT-3’ motif which is a core promoter element at these genes. Seems to also mediate the transcription of NF1. Does not bind the TATA box.
Subunit / interactions. Binds TFIIA and TFIIB.
Subcellular location. Cytoplasm. Nucleus.
Tissue specificity. Ubiquitously expressed, with highest levels in the testis and ovary.
Similarity. Belongs to the TBP family.
RefSeq proteins (2): NP_001240605, NP_004856* (*=MANE)
Domains & families (InterPro)
| ID | Name | Type |
|---|---|---|
| IPR000814 | TBP | Family |
| IPR012295 | TBP_dom_sf | Homologous_superfamily |
| IPR015445 | TBP-like | Family |
Pfam: PF00352
UniProt features (2 total): chain 1, sequence conflict 1
Structure
Experimental structures (PDB)
0 structures.
Predicted structure (AlphaFold)
| Model | pLDDT | Fraction very-high |
|---|---|---|
| AF-P62380-F1 | 95.16 | 0.94 |
Function
Pathways and Gene Ontology
Reactome pathways
0 pathways
MSigDB gene sets: 257 (showing top):
TGCTGCT_MIR15A_MIR16_MIR15B_MIR195_MIR424_MIR497, GOBP_VESICLE_ORGANIZATION, GCANCTGNY_MYOD_Q6, GOBP_PYRIMIDINE_NUCLEOSIDE_TRIPHOSPHATE_BIOSYNTHETIC_PROCESS, THEILGAARD_NEUTROPHIL_AT_SKIN_WOUND_DN, GOBP_ORGANOPHOSPHATE_METABOLIC_PROCESS, RACCACAR_AML_Q6, MEF2_02, GOBP_NUCLEOSIDE_PHOSPHATE_BIOSYNTHETIC_PROCESS, GOBP_MALE_GAMETE_GENERATION, GOBP_ORGANOPHOSPHATE_BIOSYNTHETIC_PROCESS, EFC_Q6, GOBP_CARBOHYDRATE_DERIVATIVE_METABOLIC_PROCESS, AACWWCAANK_UNKNOWN, GOBP_NUCLEOBASE_CONTAINING_SMALL_MOLECULE_METABOLIC_PROCESS
GO Biological Process (7): acrosome assembly (GO:0001675), dTTP biosynthetic process (GO:0006235), DNA-templated transcription initiation (GO:0006352), transcription by RNA polymerase II (GO:0006366), spermatid nucleus differentiation (GO:0007289), spermatogenesis (GO:0007283), nucleobase-containing compound biosynthetic process (GO:0034654)
GO Molecular Function (5): RNA polymerase II core promoter sequence-specific DNA binding (GO:0000979), RNA polymerase II general transcription initiation factor activity (GO:0016251), general transcription initiation factor activity (GO:0140223), DNA binding (GO:0003677), protein binding (GO:0005515)
GO Cellular Component (4): male germ cell nucleus (GO:0001673), transcription factor TFIIA complex (GO:0005672), cytoplasm (GO:0005737), nucleus (GO:0005634)
GO top-level categories
Rollup of top GO terms by namespace:
| Category | Terms |
|---|---|
| DNA-templated transcription | 3 |
| developmental process involved in reproduction | 2 |
| spermatid development | 2 |
| cellular component assembly involved in morphogenesis | 1 |
| cellular process involved in reproduction in multicellular organism | 1 |
| secretory granule organization | 1 |
| organelle assembly | 1 |
| deoxyribonucleoside triphosphate biosynthetic process | 1 |
| pyrimidine deoxyribonucleoside triphosphate biosynthetic process | 1 |
| pyrimidine deoxyribonucleotide biosynthetic process | 1 |
| dTTP metabolic process | 1 |
| RNA biosynthetic process | 1 |
| nucleus organization | 1 |
| male gamete generation | 1 |
| nucleobase-containing compound metabolic process | 1 |
| biosynthetic process | 1 |
| RNA polymerase II transcription regulatory region sequence-specific DNA binding | 1 |
| core promoter sequence-specific DNA binding | 1 |
| transcription by RNA polymerase II | 1 |
| general transcription initiation factor activity | 1 |
| molecular_function | 1 |
| nucleic acid binding | 1 |
| binding | 1 |
| germ cell nucleus | 1 |
| RNA polymerase II, holoenzyme | 1 |
| RNA polymerase II transcription regulator complex | 1 |
| intracellular anatomical structure | 1 |
| cellular anatomical structure | 1 |
| intracellular membrane-bounded organelle | 1 |
Protein interactions and networks
STRING
2844 interactions, top by confidence (×1000):
| Protein A | Protein B | Partner UniProt | Score |
|---|---|---|---|
| TBPL1 | GTF2A1 | P52655 | 858 |
| TBPL1 | GTF2B | Q00403 | 813 |
| TBPL1 | TAF7L | Q5H9L4 | 751 |
| TBPL1 | CREM | Q03060 | 703 |
| TBPL1 | HPR | P00739 | 692 |
| TBPL1 | TERF1 | P54274 | 677 |
| TBPL1 | POLI | Q9UNA4 | 659 |
| TBPL1 | CTNNB1 | P35222 | 630 |
| TBPL1 | APOL1 | O14791 | 623 |
| TBPL1 | NUBPL | Q8TB37 | 599 |
| TBPL1 | LINGO2 | Q7L985 | 598 |
| TBPL1 | TAF7 | Q15545 | 594 |
| TBPL1 | GTF2A1L | Q9UNN4 | 557 |
| TBPL1 | TAF2 | Q6P1X5 | 546 |
| TBPL1 | ZBED1 | O96006 | 539 |
IntAct
173 interactions, top by confidence:
| A | B | Type | Score |
|---|---|---|---|
| GTF2A1 | TBPL1 | psi-mi:“MI:0915”(physical association) | 0.850 |
| TBPL1 | GTF2A1 | psi-mi:“MI:0915”(physical association) | 0.850 |
| GTF2A1 | TBP | psi-mi:“MI:0914”(association) | 0.740 |
| TBPL1 | DVL3 | psi-mi:“MI:0915”(physical association) | 0.680 |
| TBPL1 | DVL3 | psi-mi:“MI:0407”(direct interaction) | 0.680 |
| TNNT1 | TBPL1 | psi-mi:“MI:0915”(physical association) | 0.560 |
| TBPL1 | TNNT1 | psi-mi:“MI:0915”(physical association) | 0.560 |
| TBPL1 | LSM5 | psi-mi:“MI:0915”(physical association) | 0.560 |
| GRN | TBPL1 | psi-mi:“MI:0915”(physical association) | 0.560 |
| TBPL1 | WFS1 | psi-mi:“MI:0915”(physical association) | 0.560 |
| TBPL1 | RNF11 | psi-mi:“MI:0915”(physical association) | 0.560 |
| GTF2A1 | INPPL1 | psi-mi:“MI:0914”(association) | 0.530 |
| TBPL1 | MAST2 | psi-mi:“MI:0407”(direct interaction) | 0.440 |
| TBPL1 | TAMALIN | psi-mi:“MI:0407”(direct interaction) | 0.440 |
| TBPL1 | MAST1 | psi-mi:“MI:0407”(direct interaction) | 0.440 |
| PARD3B | TBPL1 | psi-mi:“MI:0407”(direct interaction) | 0.440 |
| TBPL1 | NHERF4 | psi-mi:“MI:0407”(direct interaction) | 0.440 |
| TBPL1 | PDZD7 | psi-mi:“MI:0407”(direct interaction) | 0.440 |
| TBPL1 | LIN7C | psi-mi:“MI:0407”(direct interaction) | 0.440 |
| APBA3 | TBPL1 | psi-mi:“MI:0407”(direct interaction) | 0.440 |
| TBPL1 | LNX1 | psi-mi:“MI:0407”(direct interaction) | 0.440 |
| TBPL1 | TIAM2 | psi-mi:“MI:0407”(direct interaction) | 0.440 |
BioGRID (53): TBPL1 (Affinity Capture-MS), TBPL1 (Two-hybrid), TBPL1 (Affinity Capture-MS), TBPL1 (Reconstituted Complex), TBPL1 (Reconstituted Complex), TBPL1 (Affinity Capture-Western), TP53 (Affinity Capture-Western), TBPL1 (Affinity Capture-MS), GTF2A1 (Affinity Capture-MS), GTF2A2 (Affinity Capture-MS), PMVK (Affinity Capture-MS), TBPL1 (Biochemical Activity), TBPL1 (Affinity Capture-MS), TBPL1 (Affinity Capture-MS), TBPL1 (Affinity Capture-MS)
ESM2 similar proteins: A0B5H8, A6ZQM4, A7UFC2, B3LQ11, B7XHS8, C4M7H7, O13270, O17488, O43133, O45211, P13393, P17871, P26355, P27633, P29037, P32086, P35875, P39677, P52653, P53360, P53361, P62340, P62380, P91809, Q07953, Q12731, Q1JPY4, Q27850, Q27896, Q28DH2, Q28GG8, Q32LB1, Q4R848, Q54N48, Q54QA6, Q550C8, Q5R7U8, Q5U385, Q5UE94, Q6DIY4
Diamond homologs: A0B5H8, A1RSQ1, A3MV36, A5UL47, A6H907, A6H909, A6URP5, A6UTF6, A6VIP7, A7UFC2, A9A840, B1Y949, B6YXI6, C4M7H7, C6A0R1, D4GZA2, D4H071, O13270, O17488, O27664, O29874, O43133, O45211, O52004, O52018, O58737, P13393, P17871, P20226, P20227, P26354, P26355, P26356, P26357, P27633, P28147, P28148, P29037, P32085, P32086
SIGNOR signaling
1 interactions.
| A | Effect | B | Mechanism |
|---|---|---|---|
| CHEK2 | “down-regulates activity” | TBPL1 | phosphorylation |
Enriched among interaction partners
Reactome pathways and GO biological processes over-represented among this gene’s 106 IntAct physical interaction partners (hypergeometric vs the genome-wide background, BH-FDR, gene-set size 15–500, ranked by fold). A functional readout of the neighbourhood — distinct from this gene’s own memberships above, and biased toward well-studied / hub proteins, so read it as themes rather than proof.
Reactome pathways:
| Pathway | Partners | Fold | FDR |
|---|---|---|---|
| Ras activation upon Ca2+ influx through NMDA receptor | 5 | 39.1× | 9e-06 |
| Unblocking of NMDA receptors, glutamate binding and activation | 5 | 37.2× | 9e-06 |
| Negative regulation of NMDA receptor-mediated neuronal transmission | 5 | 37.2× | 9e-06 |
| Assembly and cell surface presentation of NMDA receptors | 10 | 34.8× | 3e-11 |
| Dopamine Neurotransmitter Release Cycle | 5 | 34.0× | 1e-05 |
| Long-term potentiation | 5 | 32.6× | 1e-05 |
| Neurexins and neuroligins | 11 | 29.7× | 2e-11 |
| Protein-protein interactions at synapses | 7 | 25.5× | 9e-07 |
GO biological processes:
| GO term | Partners | Fold | FDR |
|---|---|---|---|
| establishment or maintenance of epithelial cell apical/basal polarity | 11 | 62.1× | 5e-15 |
| protein localization to synapse | 6 | 44.6× | 5e-07 |
| receptor clustering | 7 | 42.4× | 7e-08 |
| regulation of postsynaptic membrane neurotransmitter receptor levels | 7 | 33.7× | 3e-07 |
| cell-cell adhesion | 10 | 9.9× | 8e-06 |
| protein-containing complex assembly | 8 | 8.8× | 2e-04 |
| chemical synaptic transmission | 7 | 5.2× | 1e-02 |
| intracellular signal transduction | 11 | 4.1× | 3e-03 |
Disease & clinical
Clinical variants and AI predictions
ClinVar
13 variants total. Per-class counts are floors (≥ shown; pagination cap):
| Classification | Count (floor) |
|---|---|
| Pathogenic | 0 |
| Likely pathogenic | 0 |
| Uncertain significance | 5 |
| Likely benign | 0 |
| Benign | 0 |
Top pathogenic / likely-pathogenic (0)
SpliceAI
1110 predictions. Top by Δscore:
| Variant | Effect | Δscore |
|---|---|---|
| 6:133980073:A:AG | acceptor_gain | 1.0000 |
| 6:133980074:T:G | acceptor_gain | 1.0000 |
| 6:133980076:TCTCA:T | acceptor_loss | 1.0000 |
| 6:133980077:CTCAG:C | acceptor_loss | 1.0000 |
| 6:133980078:TCA:T | acceptor_loss | 1.0000 |
| 6:133980079:CAGG:C | acceptor_loss | 1.0000 |
| 6:133980080:A:AG | acceptor_gain | 1.0000 |
| 6:133980080:AG:A | acceptor_gain | 1.0000 |
| 6:133980080:AGGAT:A | acceptor_gain | 1.0000 |
| 6:133980081:G:GC | acceptor_gain | 1.0000 |
| 6:133980081:GG:G | acceptor_gain | 1.0000 |
| 6:133980081:GGA:G | acceptor_gain | 1.0000 |
| 6:133980081:GGAT:G | acceptor_gain | 1.0000 |
| 6:133980081:GGATG:G | acceptor_gain | 1.0000 |
| 6:133980256:TTGGA:T | donor_gain | 1.0000 |
| 6:133980258:GGA:G | donor_gain | 1.0000 |
| 6:133980259:GA:G | donor_gain | 1.0000 |
| 6:133980259:GAG:G | donor_gain | 1.0000 |
| 6:133980259:GAGT:G | donor_loss | 1.0000 |
| 6:133980260:AGTA:A | donor_loss | 1.0000 |
| 6:133980261:G:GG | donor_gain | 1.0000 |
| 6:133980262:TAA:T | donor_loss | 1.0000 |
| 6:133982567:GAAA:G | acceptor_gain | 1.0000 |
| 6:133982807:A:AG | acceptor_gain | 1.0000 |
| 6:133982808:A:AG | acceptor_gain | 1.0000 |
| 6:133982809:A:AG | acceptor_gain | 1.0000 |
| 6:133982810:A:AG | acceptor_gain | 1.0000 |
| 6:133982812:C:A | acceptor_gain | 1.0000 |
| 6:133982815:A:AG | acceptor_gain | 1.0000 |
| 6:133982816:G:GC | acceptor_gain | 1.0000 |
AlphaMissense
1212 scored. Top likely-pathogenic:
| Variant | Protein change | am_pathogenicity |
|---|---|---|
| 6:133982605:C:A | A58D | 1.000 |
| 6:133982623:G:A | G64E | 1.000 |
| 6:133982623:G:T | G64V | 1.000 |
| 6:133984644:T:C | F152L | 1.000 |
| 6:133984646:T:A | F152L | 1.000 |
| 6:133984646:T:G | F152L | 1.000 |
| 6:133984654:G:A | G155E | 1.000 |
| 6:133984654:G:T | G155V | 1.000 |
| 6:133980202:T:C | L26S | 0.999 |
| 6:133982604:G:C | A58P | 0.999 |
| 6:133982611:T:A | I60N | 0.999 |
| 6:133982622:G:A | G64R | 0.999 |
| 6:133982622:G:C | G64R | 0.999 |
| 6:133982634:T:C | C68R | 0.999 |
| 6:133982636:C:G | C68W | 0.999 |
| 6:133982641:G:A | G70E | 0.999 |
| 6:133982827:G:C | A77P | 0.999 |
| 6:133982837:G:A | G80D | 0.999 |
| 6:133982840:C:A | A81D | 0.999 |
| 6:133982855:G:C | R86P | 0.999 |
| 6:133984407:T:A | V105D | 0.999 |
| 6:133984412:G:C | A107P | 0.999 |
| 6:133984413:C:A | A107E | 0.999 |
| 6:133984430:T:C | F113L | 0.999 |
| 6:133984432:T:A | F113L | 0.999 |
| 6:133984432:T:G | F113L | 0.999 |
| 6:133984644:T:A | F152I | 0.999 |
| 6:133984644:T:G | F152V | 0.999 |
| 6:133986961:G:A | G161E | 0.999 |
| 6:133980170:T:A | N15K | 0.998 |
dbSNP variants (sampled 300 via entrez): RS1000023863 (6:133959329 G>A), RS1000068185 (6:133968621 C>G,T), RS1000185644 (6:133974562 C>T), RS1000196692 (6:133971894 G>A), RS1000332130 (6:133971625 T>C), RS1000452551 (6:133978552 C>T), RS1000489439 (6:133965936 G>A), RS1000511043 (6:133985810 C>T), RS1000597856 (6:133985190 A>C), RS1000704557 (6:133978996 A>AT), RS1000767960 (6:133980438 T>C), RS1000832374 (6:133954575 C>A), RS1000886755 (6:133978767 A>T), RS1000987894 (6:133986044 C>T), RS1001025780 (6:133961154 T>A,C)
Disease associations
OMIM: gene MIM:605521 | disease phenotypes:
GenCC curated gene-disease
Mondo (0):
Orphanet (0):
HPO phenotypes
0 total (0 of 0 shown, HPO-id order):
GWAS associations
3 associations (top):
| Study | Trait | p-value |
|---|---|---|
| GCST003542_172 | Night sleep phenotypes | 1.000000e-06 |
| GCST008163_80 | Height | 6.000000e-06 |
| GCST009467_3 | Hemoglobin levels | 3.000000e-06 |
EFO canonical traits (1, from GWAS)
| EFO ID | Trait name |
|---|---|
| EFO:0004509 | hemoglobin measurement |
Drugs & pharmacology
Drug and pharmacology data
Is drug target: no
PharmGKB: 1 entry (VIP=true, CPIC=false)
CTD chemical–gene interactions
35 total (human), top 30 by PubMed support.
| Chemical | Actions (top 5) | PubMed papers |
|---|---|---|
| sodium arsenite | affects methylation, decreases expression, affects cotreatment, increases abundance, increases expression | 4 |
| Valproic Acid | affects expression, decreases methylation, increases expression | 2 |
| Cyclosporine | increases expression | 2 |
| Aflatoxin B1 | affects expression, decreases methylation | 2 |
| 3-((6-(2-methoxyphenyl)pyrimidin-4-yl)amino)phenyl)methane sulfonamide | decreases expression | 1 |
| GSK-J4 | increases expression | 1 |
| dicrotophos | decreases expression | 1 |
| pirinixic acid | affects binding, decreases expression, increases activity | 1 |
| arsenite | affects binding, increases reaction | 1 |
| butyraldehyde | increases expression | 1 |
| perfluorooctanoic acid | increases expression | 1 |
| manganese chloride | increases abundance, increases expression, affects cotreatment | 1 |
| aflatoxin B2 | decreases methylation | 1 |
| beta-methylcholine | affects expression | 1 |
| perfluorooctane sulfonic acid | increases expression | 1 |
| CGP 52608 | increases reaction, affects binding | 1 |
| chloropicrin | increases expression | 1 |
| deguelin | increases expression | 1 |
| corosolic acid | decreases expression | 1 |
| PCI 5002 | affects cotreatment, increases expression | 1 |
| Acetaminophen | increases expression | 1 |
| Air Pollutants | increases abundance, decreases expression | 1 |
| Arsenic | affects cotreatment, increases abundance, increases expression | 1 |
| Benzo(a)pyrene | increases methylation | 1 |
| Dimethyl Sulfoxide | increases expression | 1 |
| Manganese | increases abundance, increases expression, affects cotreatment | 1 |
| Phenobarbital | affects expression | 1 |
| Rotenone | increases expression | 1 |
| Tobacco Smoke Pollution | increases expression | 1 |
| Urethane | increases expression | 1 |
Cellosaurus cell lines
1 cell lines: 1 telomerase immortalized cell line
First 10 cell lines (id-ordered, not curated):
| Cellosaurus | Name | Category | Sex |
|---|---|---|---|
| CVCL_C3KK | N/Tert-1 TBPL1 | Telomerase immortalized cell line | Male |
Clinical trials (associated diseases)
0 trials via MONDO — disease-level, not drug-specific.
Related Atlas pages
No linked Atlas pages yet — the cross-entity mesh grows as the corpus expands.